Real-life use of talimogene laherparepvec (T-VEC) in melanoma patients in centers in Austria, Switzerland and Germany.

Julia Maria Ressler; Matthias Karasek; Lukas Koch; Rita Silmbrod; Joanna Mangana; Sofiya Latifyan; Veronica Aedo-Lopez; Helmut Kehrer; Felix Weihsengruber; Peter Koelblinger; Christian Posch; Julian Kofler; Olivier Michielin; Erika Richtig; Christine Hafner; Christoph Hoeller

doi:10.1136/jitc-2020-001701

Real-life use of talimogene laherparepvec (T-VEC) in melanoma patients in centers in Austria, Switzerland and Germany.

Julia Maria Ressler
, Matthias Karasek
, Lukas Koch
, Rita Silmbrod
, Joanna Mangana
, Sofiya Latifyan
, Veronica Aedo-Lopez
, Helmut Kehrer
, Felix Weihsengruber
, Peter Koelblinger
, Christian Posch
, Julian Kofler
, Olivier Michielin
, Erika Richtig
, Christine Hafner
, Christoph Hoeller

Department of Dermatology and Allergology

Research output: Contribution to journal › Original Article › peer-review

40 Citations (Web of Science)

Original language	English
Journal	JOURNAL FOR IMMUNOTHERAPY OF CANCER
Volume	9
Issue number	2
DOIs	https://doi.org/10.1136/jitc-2020-001701
Publication status	Published - 2021

Access to Document

10.1136/jitc-2020-001701

Cite this

Ressler, J. M., Karasek, M., Koch, L., Silmbrod, R., Mangana, J., Latifyan, S., Aedo-Lopez, V., Kehrer, H., Weihsengruber, F., Koelblinger, P., Posch, C., Kofler, J., Michielin, O., Richtig, E., Hafner, C., & Hoeller, C. (2021). Real-life use of talimogene laherparepvec (T-VEC) in melanoma patients in centers in Austria, Switzerland and Germany. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 9(2). https://doi.org/10.1136/jitc-2020-001701

@article{370f213347f94f94b3ccb55357489c5d,

title = "Real-life use of talimogene laherparepvec (T-VEC) in melanoma patients in centers in Austria, Switzerland and Germany.",

author = "Ressler, \{Julia Maria\} and Matthias Karasek and Lukas Koch and Rita Silmbrod and Joanna Mangana and Sofiya Latifyan and Veronica Aedo-Lopez and Helmut Kehrer and Felix Weihsengruber and Peter Koelblinger and Christian Posch and Julian Kofler and Olivier Michielin and Erika Richtig and Christine Hafner and Christoph Hoeller",

note = "K{\"o}lblinger: Department of Dermatology, Paracelsus Medical University Salzburg, Salzburg, Austria; Lehr-KH: Department of Dermatology, Krankenhaus der Elisabethinen, Linz, Linz, Austria ",

year = "2021",

doi = "10.1136/jitc-2020-001701",

language = "English",

volume = "9",

journal = "JOURNAL FOR IMMUNOTHERAPY OF CANCER",

issn = "2051-1426",

number = "2",

}

Ressler, JM, Karasek, M, Koch, L, Silmbrod, R, Mangana, J, Latifyan, S, Aedo-Lopez, V, Kehrer, H, Weihsengruber, F, Koelblinger, P, Posch, C, Kofler, J, Michielin, O, Richtig, E, Hafner, C & Hoeller, C 2021, 'Real-life use of talimogene laherparepvec (T-VEC) in melanoma patients in centers in Austria, Switzerland and Germany.', JOURNAL FOR IMMUNOTHERAPY OF CANCER, vol. 9, no. 2. https://doi.org/10.1136/jitc-2020-001701

TY - JOUR

T1 - Real-life use of talimogene laherparepvec (T-VEC) in melanoma patients in centers in Austria, Switzerland and Germany.

AU - Ressler, Julia Maria

AU - Karasek, Matthias

AU - Koch, Lukas

AU - Silmbrod, Rita

AU - Mangana, Joanna

AU - Latifyan, Sofiya

AU - Aedo-Lopez, Veronica

AU - Kehrer, Helmut

AU - Weihsengruber, Felix

AU - Koelblinger, Peter

AU - Posch, Christian

AU - Kofler, Julian

AU - Michielin, Olivier

AU - Richtig, Erika

AU - Hafner, Christine

AU - Hoeller, Christoph

N1 - Kölblinger: Department of Dermatology, Paracelsus Medical University Salzburg, Salzburg, Austria; Lehr-KH: Department of Dermatology, Krankenhaus der Elisabethinen, Linz, Linz, Austria

PY - 2021

Y1 - 2021

U2 - 10.1136/jitc-2020-001701

DO - 10.1136/jitc-2020-001701

M3 - Original Article

C2 - 33608376

SN - 2051-1426

VL - 9

JO - JOURNAL FOR IMMUNOTHERAPY OF CANCER

JF - JOURNAL FOR IMMUNOTHERAPY OF CANCER

IS - 2

ER -